Prevalence of non-alcoholic fatty liver disease among obese children in North Kerala, India


  • Reetha G. Department of Pediatrics, 2Department of Radiology, Pariyaram Medical college, Kannur, Kerala, India
  • Mahesh P. Department of Pediatrics, 2Department of Radiology, Pariyaram Medical college, Kannur, Kerala, India



Alanine amino transferase, Non-alcoholic fatty liver disease, Obesity


Background: Obesity and related co-morbidities are increasing at an alarming pace all over the world. Non-alcoholic fatty liver disease (NAFLD) is the asymptomatic involvement of the liver mainly seen in obese individuals. NAFLD can progress to chronic liver disease and has to be identified early. The aims of our study were to determine the prevalence of nonalcoholic fatty liver disease among obese children in our local population. To determine the prevalence of abnormal liver enzymes in obese children.

Methods: Cross sectional descriptive study in a tertiary care center among children aged 5-18 years for a 1 year period. NAFLD was diagnosed based on ultrasonography. Alanine amino transferase more than 40IU/l was taken as abnormal.

Results: A total of 65 patients were enrolled in the study. The prevalence of NAFLD in the study group was 60%. 20% had elevated alanine amino transferase levels.

Conclusions: The prevalence of fatty liver in Kerala is comparable to that in the West. Since this is a public health issue more population based studies are needed on a larger group to find out the exact magnitude of the problem.


World Health Organization. Update on the Commission on Ending Childhood Obesity: report by the Director-General. World Health Organization; 2015.

Must A, Strauss RS. Risks and consequences of childhood and adolescent obesity. Int J Obes Relat Metab Disord. 1999;23(2):2-11.

Mathur P, Das MK, Arora NK. Non-alcoholic fatty liver disease and childhood obesity. Indian J Pediatr. 2007;74(4):401-7.

Marion AW, Baker AJ, Dhawan A. Fatty liver disease in children. Archives of Disease in Childhood. 2004;89:648-52.

Volovelsky O, Weiss R. Fatty liver disease in obese children relation to other metabolic risk factors. Int J Pediatr Obes. 2011;6(1):59-64.

Shneider BL, Gonzalez-Peralta R, and Roberts EA. Controversies in the management of pediatric liver disease: Hepatitis B, C and NAFLD: Summary of a single topic conference. Hepatol. 2006;44:1344-54.

Khadilkar VV, Yadav S, Agarwal KK. Revised IAP Growth Charts for Height, Weight and Body Mass Index for 5- to 18-year-old Indian Children. Indian Pediatr. 2015;52:47-55.

X Ma, Holalkere NS, Kambadakone R. Imaging-based quantification of hepatic fat: methods and clinical applications radio graphics. Lancet. 2009;29:5:1253-77.

Schwimmer JB, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents. Pediatr. 2006;118:1388-93.

Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol. 1991;43:26-8.

Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis. 2000;28:155-61.

Franzese A, Vajro P, Argenziano A, Puzziello A, Iannucci MP. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci. 1997:42:1428-32.

Strauss RS, Barlow SE, Dietz WH. Prevelance of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr. 2000;136(6):727-33.

Lira AR, Oliveira FL, Escrivão MA, Colugnati FA, Taddei JA. Hepatic steatosis in a school population of overweight and obese adolescents. Lancet. 2010;86(1):45-52.

Parry IA, Bhat RA, Zargar SA, Ganie A, Khan I. The Prevalence of Non-alcoholic Fatty Liver Disease and its Association with Metabolic Syndrome and Obesity in Pediatric Population of North India. J Metabolic Synd. 2012;1:118.

Chathurvedi K, Vohra P. Non-alcoholic Fatty Liver Disease in Children. Indian Pediatr 2012;49:757-8.

Huang SC, Yang YJ: Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level. J Pediatr. Gastroenterol Nutr. 2013;56:145-50.

Barshop NJ, Sirlin CB, Schwimmer JB, Lavine JE: Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2008;28:13-24.

Loomba R, Sirlin CB, Schwimmer JB, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Hepatol. 2009;50:1282-93.

Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatr. 2005;115:561-5.

Browning JD, Szczepaniak LS, Dobbins R. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatol. 2004;40(6):1387-95.

Angulo P, Keach JC, Batts KP, and Lindor KD, Independent predictors of liver fibrosis in patients with non-alcoholic steatohepatitis. Hepatol. 1999;30(6),1356-62.

Nobili V, Reale A, Alisi A. Elevated serum ALT in children presenting to the emergency unit: relationship with NAFLD. Dig Liver Dis. 2009;41:749-52.

Schwimmer JB, Dunn W, Norman GJ. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterol. 2010;138:1357-64.

Franzese A, Vajro P, Argenziano A, Puzziello A, Iannucci MP, Saviano MC, et al. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci. 1997;42(7):1428-32.

Engelmann G, Hoffmann GF, Grulich-Henn J, Teufel U. Alanine Aminotransferase Elevation in Obese Infants and Children: A Marker of Early Onset Non-alcoholic Fatty Liver Disease. Hepatitis Monthly. 2014;14(4):14112.






Original Research Articles